The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 09, 2021
Filed:
Feb. 20, 2019
Applicant:
Nono Inc., Toronto, CA;
Inventor:
Jonathan David Garman, Thornhill, CA;
Assignee:
NoNO Inc., Toronto, CA;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 49/00 (2006.01); C07K 2/00 (2006.01); C07K 4/00 (2006.01); C07K 5/00 (2006.01); C07K 7/00 (2006.01); C07K 14/00 (2006.01); C07K 16/00 (2006.01); A61B 5/00 (2006.01); A61K 38/17 (2006.01); A61K 38/16 (2006.01); A61K 47/26 (2006.01); A61K 38/10 (2006.01); A61K 9/00 (2006.01); A61K 47/18 (2017.01); A61K 9/19 (2006.01); A61K 47/12 (2006.01); A61K 45/06 (2006.01); A61K 38/08 (2019.01);
U.S. Cl.
CPC ...
A61K 38/177 (2013.01); A61K 9/0019 (2013.01); A61K 9/19 (2013.01); A61K 38/10 (2013.01); A61K 38/162 (2013.01); A61K 38/1787 (2013.01); A61K 47/183 (2013.01); A61K 47/26 (2013.01); A61K 38/00 (2013.01); A61K 38/08 (2013.01); A61K 45/06 (2013.01); A61K 47/12 (2013.01); A61K 2300/00 (2013.01);
Abstract
The present invention provides lyophilized formulations of active agents, particularly of TAT-NR2B9c. TAT-NR2B9c has shown promise for treating stroke, aneurysm, subarachnoid hemorrhage and other neurological or neurotraumatic conditions. Such formulations are stable at room temperature thus facilitating maintenance of supplies of such a formulation in ambulances for administration at the scene of illness or accident or in transit to a hospital.
Garman, Jonathan. (2021). Prelyophilized, lyophilized and reconstituted formulations comprising tat-nr2b9c with d-amino acids, histidine and trehalose (U.S. Patent No. 10912817). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10912817
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile